Endotoxin Adsorbent Therapy in Severe COVID-19 Pneumonia
Conclusions: We demonstrated the clinical improvement of severe COVID-19 patients with elevated EAA level upon receiving EA therapy. However, the benefit of EA therapy in COVID-19 ARDS is still unclear and needs to be elucidated with randomized controlled study.Blood Purif
Source: Blood Purification - Category: Hematology Source Type: research
More News: Coronavirus | COVID-19 | Hematology | Laboratory Medicine | Pneumonia | Polymyxin B | Respiratory Medicine | Study | Thailand Health